132 related articles for article (PubMed ID: 10864034)
1. Effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on tissue carnitine and lipid levels in rats.
Hayashi Y; Muranaka Y; Kirimoto T; Asaka N; Miyake H; Matsuura N
Biol Pharm Bull; 2000 Jun; 23(6):770-3. PubMed ID: 10864034
[TBL] [Abstract][Full Text] [Related]
2. 3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties.
Simkhovich BZ; Shutenko ZV; Meirena DV; Khagi KB; Mezapuķe RJ; Molodchina TN; Kalviņs IJ; Lukevics E
Biochem Pharmacol; 1988 Jan; 37(2):195-202. PubMed ID: 3342076
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts.
Hayashi Y; Tajima K; Kirimoto T; Miyake H; Matsuura N
Pharmacology; 2000 Nov; 61(4):238-43. PubMed ID: 11093075
[TBL] [Abstract][Full Text] [Related]
4. [Effect of DL-carnitine and gamma-butyrobetaine hydroxylase inhibitor 3-(2,2,2-trimethylhydrazinium) propionate on isoproterenol-induced changes in the metabolism of the rat myocardium].
Simkhovich BZ; Meĭrena DV; Shutenko ZhV; Khagi KhB; Briede IaL
Vopr Med Khim; 1988; 34(5):30-4. PubMed ID: 3218133
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D-carnitine and a gamma-butyrobetaine hydroxylase inhibitor.
Tsoko M; Beauseigneur F; Gresti J; Niot I; Demarquoy J; Boichot J; Bezard J; Rochette L; Clouet P
Biochem Pharmacol; 1995 May; 49(10):1403-10. PubMed ID: 7763283
[TBL] [Abstract][Full Text] [Related]
6. MET-88, a gamma-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction.
Hayashi Y; Ishida H; Hoshiai M; Hoshiai K; Kirimoto T; Kanno T; Nakano M; Tajima K; Miyake H; Matsuura N; Nakazawa H
Mol Cell Biochem; 2000 Jun; 209(1-2):39-46. PubMed ID: 10942199
[TBL] [Abstract][Full Text] [Related]
7. Effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on myocardial derangements induced by hydrogen peroxide in the isolated perfused rat heart.
Akahira M; Hara A; Abiko Y
Fundam Clin Pharmacol; 1997; 11(4):356-64. PubMed ID: 9263766
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of ischemic myocardial damage by reducing the intracellular free carnitine level].
Simkhovich BZ; Vitolinia RO; Stivrinia MI; Shutenko ZhV; Meĭrena DV
Kardiologiia; 1987 Jul; 27(7):85-8. PubMed ID: 3656926
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.
Hayashi Y; Kirimoto T; Asaka N; Nakano M; Tajima K; Miyake H; Matsuura N
Eur J Pharmacol; 2000 May; 395(3):217-24. PubMed ID: 10812052
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of an animal model of carnitine deficiency.
Spaniol M; Brooks H; Auer L; Zimmermann A; Solioz M; Stieger B; Krähenbühl S
Eur J Biochem; 2001 Mar; 268(6):1876-87. PubMed ID: 11248709
[TBL] [Abstract][Full Text] [Related]
11. [The effect of a structural analog of gamma-butyrobetaine, mildronate, [3-2,2,2-trimethylhydrazine)propionate] on dynamic carnitine-dependent metabolism].
Shutenko ZhV; Priedena IA; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1991; 37(3):24-6. PubMed ID: 1949676
[TBL] [Abstract][Full Text] [Related]
12. Effect of 3-(2,2,2-trimethylhydrazinium) propionate, gamma-butyrobetaine hydroxylase inhibitor, on isoproterenol-induced mitochondrial dysfunction.
Hanaki Y; Sugiyama S; Ozawa T
Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):157-60. PubMed ID: 2546223
[TBL] [Abstract][Full Text] [Related]
13. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
Liepinsh E; Vilskersts R; Loca D; Kirjanova O; Pugovichs O; Kalvinsh I; Dambrova M
J Cardiovasc Pharmacol; 2006 Dec; 48(6):314-9. PubMed ID: 17204911
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of the rat liver gamma-butyrobetaine hydroxylase.
Galland S; Le Borgne F; Guyonnet D; Clouet P; Demarquoy J
Mol Cell Biochem; 1998 Jan; 178(1-2):163-8. PubMed ID: 9546596
[TBL] [Abstract][Full Text] [Related]
15. Carnitine depletion in rat pups from mothers given mildronate: a model of carnitine deficiency in late fetal and neonatal life.
Peschechera A; Scalibastri M; Russo F; Giarrizzo MG; Carminati P; Giannessi F; Arduini A; Ricciolini R
Life Sci; 2005 Oct; 77(24):3078-91. PubMed ID: 15979102
[TBL] [Abstract][Full Text] [Related]
16. [Effect of a new structural analog of gamma-butyrobetaine-- 3-(2,2,2-trimethylhydrazine)propionate (THP) on carnitine level, carnitine-dependent fatty acid oxidation and various indices of energy metabolism in the myocardium].
Simkhovich BZ; Meĭrena DV; Khagi KhB; Kalvin'sh IIa; Lukevits EIa
Vopr Med Khim; 1986; 32(4):72-6. PubMed ID: 3765501
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on energy metabolism in ischemic dog hearts.
Kirimoto T; Nobori K; Asaka N; Muranaka Y; Tajima K; Miyake H
Arch Int Pharmacodyn Ther; 1996; 331(2):163-78. PubMed ID: 8937627
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term mildronate treatment on cardiac and liver functions in rats.
Liepinsh E; Kuka J; Svalbe B; Vilskersts R; Skapare E; Cirule H; Pugovics O; Kalvinsh I; Dambrova M
Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):387-94. PubMed ID: 19663820
[TBL] [Abstract][Full Text] [Related]
19. Carnitine biosynthesis in hepatic peroxisomes. Demonstration of gamma-butyrobetaine hydroxylase activity.
Paul HS; Sekas G; Adibi SA
Eur J Biochem; 1992 Feb; 203(3):599-605. PubMed ID: 1735445
[TBL] [Abstract][Full Text] [Related]
20. Hypolipidaemic effects of fenofibrate are not altered by mildronate-mediated normalization of carnitine concentration in rat liver.
Tsoko M; Beauseigneur F; Gresti J; Demarquoy J; Clouet P
Biochimie; 1998 Nov; 80(11):943-8. PubMed ID: 9893954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
